U.S., July 1 -- ClinicalTrials.gov registry received information related to the study (NCT07677163) titled 'A Clinical Trial of MK-1403 in Healthy Participants (MK-1403-007)' on June 24.
Brief Summary: The purpose of this trial is to learn about a trial medicine called MK-1403. Researchers designed MK-1403 to treat a type of heart and blood vessel disease called atherosclerotic cardiovascular disease (ASCVD).
Before giving a trial medicine to people with a health condition, researchers first do clinical trials in healthy people. This trial will help researchers learn about the safety of MK-1403 and if participants tolerate it. Tolerate means participants receive the trial medicine and they do not need to stop taking it due to health probl...